Trial
NCT02451891
A Phase I Study to Assess Ebola Vaccines cAd3-EBO Z and MVA-EBO Z
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Oxford
Collaborators
—
Condition
Ebola Virus Disease
Intervention
MVA-EBO Z
Why stopped
Long term follow up will take place in a new clinical trial.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-18